Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 22126

Страница 1 из 2213

Renal cell carcinoma drug and cell therapy: today and tomorrowThe paper also looks at clinically applicable targeted immune drugs and the principle

New anti-mesothelin single-domain antibodies and cell models for developing targeted breast cancer therapy (MSLN), a cell surface antigen and one of the preferred targets for the therapy of solid tumors. Most

One-Pot Time-Induced Proteome Integral Solubility Alteration Assay for Automated and Sensitive Drug-Target Identification-induced (OPTI)-PISA. Here, we demonstrate OPTI-PISA performance on identifying targets of multiple drugs in cell

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies antigens as molecular targets in immunotherapy, including the application of T cell receptor mimic (TCRm

Target Cells for Stem Cell Factor in the Adult Islets of Langerhans, Simultaneously Synthesizing Glucagon and Insulin
© 2017, Springer Science+Business Media, LLC. C-kit—a stem cell receptor, or CD117, is one

Cell targets of antitumor ribonucleasesSeveral ribonucleases (RNases) are known to exert a toxic effect on tumor cells, but the mechanism

Artificial Glycoproteins as a Scaffold for Targeted Drug Therapy,” the glycocalyx is a glycan-enriched cellular coating that plays a crucial role in mediating cell-to-cell

Targeted and theranostic applications for nanotechnologies in medicine: Cell-surface engineering with magnetic nanoparticles for regenerative and bioanalytical applications, such as cell delivery and tissue engineering, need a powerful methodology to manipulate with live biological

Generation of recombinant adenoviral vectors encoding neural cell adhesion molecules ncam1, ncam2 and l1cam genes to increase the efficiency of gene-cell therapeutics delivery to target organ. © Human stem cells

Differentiating Induced Pluripotent Stem Cells into Natural Killer Cells for Adoptive Cell Immunotherapies—Comparative Characterization of Current Protocols, we analyze existing protocols for targeted differentiation of human iPSCs into NK cells with a focus

Страница 1 из 2213